top of page
AUB Group Ltd

AUB Group Ltd – Fund Manager Investment Commentary & Insights

ASX:AUB

Multiline Insurance & Brokers

Fund Manager Summary on AUB Group Ltd (ASX:AUB)

In March 2026, Pendal Group commented that AUB Group delivered a 1H26 result in line with consensus and modestly upgraded FY26 NPAT guidance, but the stock weakened as investors focused on softening premium rates and AI disruption risks leaving valuation at historically low multiples. AUB Group Ltd (ASX:AUB) is viewed by fund managers as a high-quality insurance broking platform with structural tailwinds from favourable premium cycles, customer growth and scale benefits from acquisitions (including Tysers, BizCover and agency expansion), a strong balance sheet that supports further M&A, and experienced management; recent commentary reflects a mix of opportunity and execution risk — managers highlight upside from margin improvement and successful integration of recent deals, and note takeover interest evidenced by a non-binding $45 per share proposal (c.40% premium) and subsequent consortium activity, while also flagging risks from a potential softening premium rate cycle, NZ weakness and FX headwinds, AI-related disruption fears, and the uncertainty that followed the failed bid which drove event‑driven volatility; valuation is a central strategic consideration with AUB trading materially below peers (brokers have derated from ~25x to ~15x and AUB is trading near ~11x FY27 PE, having been cited around 15x PE and a 20–30% discount to global peers in earlier notes), so actionable focus for investors and managers is on tracking premium rate trends, delivery of synergies and margins from acquisitions, adherence to guidance and NPAT trajectory, balance sheet deployment for accretive deals, and likelihood of renewed M&A or other catalysts to close the valuation gap.

Commentary From The Managers

There are 13 insights from 8 fund managers regarding their investment in AUB Group Ltd (ASX:AUB) available on Thesis Tracker.

Unlock Updates With ThesisTracker Pro

Don’t let information asymmetry undermine your investment returns. Join other engaged investors on ThesisTracker Pro.

Updates are made available to members within 12 hours of being released. ​The completeness, accuracy or current status of the investments referenced are not guaranteed. 

Commentary From The Managers

Pendal Group

2 Mar 2026

$25.32

Summary

  • Pendal Group believes AUB is materially mispriced and continues to hold because 1H26 results were broadly in line with consensus, the FY26 NPAT upgrade was modest, the sell‑off reflects sentiment‑driven de‑rating rather than earnings deterioration, and the stock now trades at historically cheap valuations — while acknowledging timing of any sentiment recovery is uncertain.
  • 1H26 result: In line with consensus; FY26 NPAT guidance upgraded by +1.5% at the midpoint.
  • Drivers: Stronger‑than‑expected performance from BizCover and Agencies, partly offset by New Zealand weakness and FX headwinds.
  • No material earnings revisions: Consensus was already at the midpoint of the new range, so reported results did not prompt significant estimate changes.
  • Market reaction: Share price fell ~5% as investors focused on softening premium rates and AI disruption risks.
  • Sector derating: Global insurance brokers have derated ~40% (from ~25x to ~15x PE) over the past year; AUB has derated ~50% from its peak.
  • Valuation: AUB trades at ~11x FY27 PE, the cheapest absolute and relative valuation since IPO in 2006 (excluding the GFC period).
  • Nature of decline: The move has been an almost pure de‑rating rather than evidence of material earnings deterioration.
  • Implied risk pricing: Current market pricing appears to embed more than cyclical risk and assigns significant secular risk to the business.
  • Pendal view on outlook: Believes these fears are overdone, but the timing of a recovery in sentiment remains uncertain.

Pengana Capital

28 Feb 2026

$25.32

Summary

  • Pengana Capital believes AUB Group has been unfairly affected by short-term market concerns and increased their position because the business is very stable, holds an excellent market position and was acquired at a free cash flow yield of 10%
  • AI fear trade has driven sentiment-driven selling, creating a valuation dislocation relative to fundamentals
  • Very stable business model with recurring, commission-based revenues and predictable cash flows
  • Excellent market position — leading distribution franchises, strong broker relationships and scale advantages in core markets
  • Attractive free cash flow profile (≈10% FCF yield), high cash conversion and low ongoing capital intensity
  • Growth optionality through bolt-on acquisitions and cross-selling to an entrenched client base; proven M&A execution supports expansion
  • Disciplined capital allocation — ability to return capital via dividends/share buybacks while funding growth
  • Balance sheet strength and conservative underwriting reduce downside risk versus headline market fears
  • Valuation provides a margin of safety relative to long-term earnings and cash generation
  • Ongoing monitoring of AI impacts, but current assessment is that structural fundamentals remain intact and the dislocation presents a buying opportunity

Totus Capital

31 Dec 2025

$30.80

Summary

  • Totus Capital notes a significant decline in AUB's share price, falling by 17% following a failed bid from private equity.
  • Despite this setback, AUB's stock remains 4% lower than its pre-bid price.
  • Management has re-affirmed guidance for NPAT growth between 7-13%.
  • Prior to the bid, Totus Capital was actively accumulating a position in AUB.
  • The recent stock weakness provided an opportunity to increase holdings to just over 4% of the portfolio.
  • AUB currently trades at a 15x PE ratio, representing a 20-30% discount compared to global peers.

Perennial Partners

31 Dec 2025

$30.80

Summary

  • Perennial Partners believes the announcement that EQT and CVC do not intend to proceed at $45.00 per share is disappointing in the short term and continues to hold because the offer failed to include a meaningful premium to historical valuation multiples, leaving material upside over the medium term.
  • Deal update: EQT and CVC have indicated they will not proceed with the acquisition at the agreed price.
  • Short-term reaction: the update is a negative catalyst for near‑term share price performance and market sentiment.
  • Valuation perspective: the $45.00 offer did not represent a significant premium to AUB’s historical multiples, implying the bid undervalued the company on a normalized basis.
  • Medium-term thesis: Perennial expects significant upside as the business fundamentals and valuation re‑rate over time.
  • Positioning: Perennial remains invested to capture the anticipated medium‑term re‑rating and views the current price as understating long‑term value.

SG Hiscock & Company

31 Dec 2025

$30.80

Summary

  • SG Hiscock & Company believes AUB remains fundamentally attractive and continues to hold because the private equity outcome did not change the business outlook, management’s disciplined execution endures, and FY26 guidance was reaffirmed.
  • Takeover optionality removed: A private equity consortium elected not to proceed with a binding offer after due diligence on its nonbinding $45.00 per share proposal, eliminating near‑term deal optionality.
  • Share price reaction: The December pullback was driven largely by event‑driven and fast‑money investors exiting positions established around the bid, not by a deterioration in fundamentals.
  • Fundamentals intact: AUB reaffirmed FY26 earnings guidance and we see no operational change that undermines the investment case.
  • Confidence in management: Management’s long track record of disciplined execution, accretive M&A and value creation for shareholders underpins our conviction and was the reason private equity showed interest.
  • Position rationale: The post‑bid repricing is viewed as an event‑driven dislocation, reinforcing our medium‑to‑long‑term conviction in AUB’s earnings trajectory.

Prime Value Asset Management

30 Nov 2025

$30.63

Summary

  • Prime Value Asset Management continues to hold its investment in AUB while assessing the company's prospects.
  • Evaluation includes the scenario of a softening insurance premium rate cycle.
  • Consideration of AUB's ability to utilize its strong balance sheet for acquisitions.
  • AUB's appeal lies in its strong growth profile and consistent profits from small business owner clients.
  • Clients purchase insurance to protect assets and comply with regulatory requirements.
  • All positions are believed to offer significant appreciation potential individually.
  • The Fund's diversification aims for potentially better-than-market returns with less risk.
  • Diversification does not guarantee profit or protect against loss.

Pendal Group

3 Nov 2025

$36.43

Summary

  • Pendal Group updates its investment thesis on AUB Group Ltd.
  • AUB Group received a non-binding indicative bid from EQT at $45 per share.
  • The bid represents a 40% premium compared to the undisturbed price.
  • EQT has a six-week period for exclusive due diligence.
  • The bid supports the view that AUB was materially undervalued.
  • Currently, AUB stock is trading at a 20% discount to the bid price.
  • This discount reflects the risk that the transaction may not be completed.

Perennial Partners

31 Oct 2025

$36.94

Summary

  • Perennial Partners update: updating their investment thesis on AUB Group following a material share-price move.
  • Share-price move: AUB Group shares rose ~12.9% after the announcement.
  • Indicative proposal: Perennial Partners notes a non-binding private equity proposal at ~40% premium to AUB’s undisturbed price.
  • Deal uncertainty: the proposal is non-binding and risks remain on completion (eg. due diligence, regulatory approval, competing bids).
  • Position management: Perennial Partners reduced their position size at the higher prices relative to month end.
  • Broader implication: the event highlights the attractive value in the remainder of the portfolio, which may attract interest from other M&A players.

Yarra Capital Management

31 Oct 2025

$36.94

Summary

  • Yarra Capital Management believes AUB Group is attractively positioned and continues to hold because of its quality recurring brokerage earnings, ongoing consolidation tailwinds and the potential shareholder value catalyst from the unsolicited EQT proposal
  • Outperformance trigger — share price outperformed after an unsolicited takeover proposal from EQT AB valuing AUB at approximately $5.25 billion, a 25% premium to the prior close
  • Business model — diversified insurance broking platform with high proportions of fee-based, recurring revenue and attractive unit economics supporting margin resilience
  • Growth runway — strong organic growth through premium volumes plus a clear M&A pipeline to drive earnings per share accretion and scale benefits
  • Capital allocation — track record of disciplined deployment of capital including reinvestment in the network, dividends and opportunistic buybacks
  • Balance sheet and cash generation — cash generative operations and conservative balance sheet that support growth and shareholder returns
  • Valuation and upside — EQT proposal frames a near-term value reference and underpins upside versus pre-offer prices while leaving optionality for further strategic outcomes
  • Key risks — deal uncertainty and timing, potential regulatory or competitor responses, integration execution on acquisitions and macro insurance cycle sensitivity

Asymmetric Asset Management

31 Oct 2025

$36.94

Summary

  • AUB Group received a non-binding indicative acquisition proposal at $45 per share.
  • Prior to the announcement, AUB's share price was $32.10.
  • The potential acquirer is EQT AB, a large Swedish private equity firm.
  • EQT has formed a consortium with CVC Asia Pacific Ltd to jointly bid for AUB.
  • The addition of CVC is viewed positively for the acquisition's completion.
  • AUB has successfully expanded overseas, showcasing its unique position in the Australian market.
  • CEO Mike Emmett is recognized for his capable leadership.
  • AUB's high quality, favorable industry dynamics, and attractive pricing make it a core position for Asymmetric Asset Management.
  • The stock trades at a material discount (~$37) to the proposed bid price.
  • AUB’s share price rose 13% for the month, with an additional ~22% upside to the bid price.

Pendal Group

31 July 2025

$33.93

Summary

  • AUB Group Ltd experienced a drift in performance over the month.
  • Pendal Group sees potential for upside due to revenue growth supported by a positive insurance premium cycle.
  • Customer growth is anticipated to contribute positively to revenue.
  • Productivity improvements and scale benefits from recent acquisitions are expected to enhance margins.
  • The current valuation remains at a discount compared to peers, partly due to the acquisition of Tysers in the UK.
  • Successful delivery on targets related to the acquisition can help close the valuation gap.

Asymmetric Asset Management

28 Feb 2025

$31.03

Summary

  • AUB Group is recognized as a leading insurance broker in Australia, enhancing its market position.
  • The company has significant overseas operations that provide ample growth opportunities.
  • Reported a double-digit growth in revenue, earnings, and dividends for the half-year period.
  • AUB Group reaffirmed double-digit growth in earnings for the full year.
  • Asymmetric Asset Management continues to hold due to strong performance metrics and growth prospects.

Yarra Capital Management

30 June 2024

$31.38

Summary

  • AUB Group (AUB, overweight) – the insurance broking business generated positive outcomes in Q2.
  • Earnings upgrade supported the stock performance.
  • Continued strong premium rate momentum observed along with strong operating performances across AUB’s segments.
  • Acquisition of Pacific Indemnity announced in May.
  • The agency business is complementary to AUB’s existing operations, promising clear revenue and cost synergies.

The completeness, accuracy or current status of the investments referenced are not guaranteed. 

Investment Ideas Scanner

Loading...

Frequently Asked Questions

Who is investing in AUB Group Ltd (ASX:AUB)?

Fund managers including Asymmetric Asset Management, Yarra Capital Management, Pendal Group, Perennial Partners, Prime Value Asset Management, Totus Capital, SG Hiscock & Company and Pengana Capital have invested in AUB Group Ltd (ASX:AUB).

Why do fund managers invest in AUB Group Ltd?

Fund managers invest in AUB Group Ltd due to its consistent double-digit revenue, earnings, and dividend growth, as well as its favorable industry dynamics. The company has robust growth prospects, driven by expanding overseas operations and acquisitions. Additionally, AUB's stock trades at a valuation discount compared to peers, which presents an attractive risk/reward profile. Recent interest from private equity further indicates its strong market position, positioning AUB as a core investment with potential for significant returns.

What happened to AUB Group Ltd (ASX:AUB)?

Fund managers are investing in AUB Group Ltd due to a recent non-binding bid from private equity firm EQT at $45 per share, representing a significant premium over previous share prices, validating their belief that AUB is undervalued. The potential acquisition highlights AUB's strong market position, consistent profitability, and growth potential. Although risks remain regarding the completion of the deal, the company's favorable industry dynamics, solid management, and prospects for further growth make it an attractive investment. Currently, AUB trades at a discount to the bid price, suggesting potential upside.

What is the short interest in AUB Group Ltd (ASX:AUB)?

The short interest in AUB Group Ltd (ASX:AUB) is 1.66% which makes it the 156th most shorted stock on the ASX. Of the 116.6M shares that AUB Group Ltd has on issue, 1.9M have been sold short.

What does AUB Group Ltd (ASX:AUB) do?

AUB Group Ltd. engages in the provision of equity-based insurance broker network. It operates through the following segments: Australian Broking, Agencies, New Zealand Broking, International, and Support Services. The Australian Broking segment provides insurance broking and advisory services primarily to SME clients. The New Zealand Broking segment focuses on the provision of broking and advisory services primarily to SME clients in New Zealand. The International segment includes wholesale and retail broking and Managing General Agents. The Support Services segment deals with the provision of a range of services to support the Australian broking, agencies, New Zealand, broking and Tysers segments, and external clients. The company was founded on November 7, 1985 and is headquartered in North Sydney, Australia.

faqs
q1
q2
q3
q4
q5

Newsletter Sign Up

Join the email list for updates.

Thesis-Tracker.com is Australia's largest professional investment commentary database. Thesis Tracker covers ASX listed companies with 5,000+ insights provided directly from financial services professionals. Thesis-Tracker.com does not enter into commercial arrangements with any of the featured financial services professionals nor publish proprietary opinions. Before making a decision please consider these and any relevant Product Disclosure Statement. Any advice on this site is general in nature and does not take into consideration your objectives, financial situation or needs.

bottom of page